Pune, India -- (SBWIRE) -- 04/19/2018 -- Deep brain stimulation device, often described as brain pacemaker, aids in alleviating symptoms of Parkinson's disease (PD). The device is implanted at one of the three FDA approved brain sites to block the electrical signals from these sites to the brain. The three FDA approved targeted brain sites are ventrointermedialis (VIM) nucleus of the thalamus, subthalamic nucleus (STN), and Globus pallidus pars interna (GPi). DBS surgery is performed on patient's suffering from Parkinson's disease for at least four years, and are on medications albeit with motor complications. Though there are other surgical options such as thalamotomy and pallidotomy, deep brain stimulation is the most preferred option, as it does not involve tissue destruction and is a reversible surgical treatment.
The market is expected to exhibit a CAGR of +8% from 2018 to 2023, rising from a valuation of US$3.8 bn to an opportunity of US$6.5 bn by 2023
Top Key Vendors in Market:
Medtronic, Boston Scientific Corporation, Enteromedics, Cyberonics, St. Jude Medical, Neuropace, Zynex, Neuronetics, Functional Neuromodulation, Microtransponder and Neurosigma.

Get Sample Copy Of this Report
@ https://www.healthcareintelligencemarkets.com/request_sample.php?id=23881

Based on finished product type, the global Deep Brain Stimulation Devicess market is divided into tablet, powder, and capsules. As per the research conducted, the capsule segment is estimated to surpass the tablet and powder segments as consumers prefer medication via capsule over any other mode of delivery. This preference can be accredited to the comfort and better absorption properties of capsules as compared to the latter two. Even, the dietary supplement application segment is expected to rule over the other ones due to the emerging trend of consuming non-genetically modified organism and natural products.

For more Information:
https://www.healthcareintelligencemarkets.com/enquiry_before_buying.php?id=23881

An assessment of the market attractiveness with regard to the competition that new players and products are likely to present to older ones has been provided in the publication. The research report also mentions the innovations, new developments, marketing strategies, branding techniques, and products of the key participants present in the global Deep Brain Stimulation Devicess market. To present a clear vision of the market the competitive landscape has been thoroughly analyzed utilizing the value chain analysis. The opportunities and threats present in the future for the key market players have also been emphasized in the publication.

The major growth drivers, challenges, and trends influencing the global Deep Brain Stimulation Devicess market are inspected at length. The report also presents a thorough qualitative and quantitative data affecting to the projected impact of these factors on market's future growth prospects. A number of analysis tools such as Porter's five forces analysis and SWOT analysis have been employed to provide an accurate understanding of this market. Also, the report is compiled in a way for the readers and customers to understand better.

Table of Content:
Global Deep Brain Stimulation Devicess Market Research Report 2018-2023
Chapter 1: Deep Brain Stimulation Devicess Market Overview
Chapter 2: Global Economic Impact
Chapter 3: Competition by Manufacturer
Chapter 4: Production, Revenue (Value) by Region (2018-2023)
Chapter 5: Supply (Production), Consumption, Export, Import by Regions (2018-2023)
Chapter 6: Production, Revenue (Value), Price Trend by Type
Chapter 7: Analysis by Application
Chapter 8: Manufacturing Cost Analysis
Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Market Forecast (2018-2023)
Chapter 13: Appendix